PubMed Health⌕ Search

Biomedical subjects

F Barranco

Publications and source records attributed to F Barranco.

10 recordsLinked to original sources

[Influence of the intravenous nitroglycerin dose on the appearance of drug tolerance].

BACKGROUND: There are few studies on the influence of different doses of intravenous nitroglycerin (NTG) on the appearance of drug tolerance. METHODS: A controlled clinical trial was performed in 40 patients admitted to an ICU with the diagnosis of acute myocardial infarction (AMI). The patients were divided into two groups: group A with a continuous perfusion of NTG at 2 mg/h, and group B with 4 mg/h. At 30 minutes of the infusion, NTG was exchanged for a placebo in half of the patients of each group (subgroups A1 and B1) with the remaining patients continuing with NTG for 24 h (A2 and B2). The hemodynamic variables studied were central venous pressure (CVP), pulmonary capillary pressure (PCP), mean pulmonary artery pressure (PAP) and mean blood pressure (BP). RESULTS: The patients in group A showed a decrease in the hemodynamic effects in all the variables studied. At 24 h of infusion no differences were observed with respect to the previous NTG values for CVP and PCP, with significant differences being maintained for PAP and BP. In group B the hemodynamic effect was maintained for all the variables during the 24 hours studied. CONCLUSIONS: In patients with acute myocardial infarction, the dosis of nitroglycerin administered was found to have a determined influence in the appearance of drug tolerance with this fact being more evident on evaluation of the effect of nitroglycerin on the venous system.

Aged↗

Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency.

OBJECTIVE: Evaluation of efficacy of intravenous flecainide to revert supraventricular arrhythmias to sinus rhythm in patients with respiratory insufficiency. DESIGN: Comparative randomized prospective trial. SETTING: ICU in a University Hospital. PATIENTS: 30 patients with acute respiratory insufficiency or acute exacerbation of chronic respiratory insufficiency and supraventricular arrhythmias. Intravenous flecainide was administered to 15 patients (Group A) (2 mg/kg for 10 min and continuous perfusion of 1.5 mg/kg for 1 h). Intravenous verapamil was administered to 15 patients (Group B) (0.15 mg/kg for 5 min and continuous perfusion of 0.005 mg/kg/min for 1 h). MEASUREMENTS AND RESULTS: The categories of patients' arrhythmias were: Group A-atrial fibrillation (AF) in 5 cases, atrial flutter (AFl) in 2, multifocal atrial tachycardia (MAT) in 4 and other supraventricular tachycardia (SVT) in 4. Group B-AF in 6 cases, AFL in 2, MAT in 2 and SVT in 5 cases. Flecainide reverted arrhythmias to sinus rhythm in 12 out of 15 cases (80%); of these 12, 11 reverted with the initial bolus. Verapamil reverted 5 out of 12 cases (33.3%, p < 0.01). No significant secondary adverse effects were detected. CONCLUSION: Intravenous flecainide is an effective antiarrhythmic drug to treat acute supraventricular arrhythmias in patients with respiratory insufficiency.

Acute Disease↗

Cardiopulmonary resuscitation with simultaneous chest and abdominal compression: comparative study in humans.

To assess the efficacy of the simultaneous application of chest and abdominal compression (SCAC) in cardiopulmonary resuscitation (CPR), we performed a prospective study on 18 patients shortly after cardiac arrest. Three different CPR procedures were carried out consecutively: (1) Standard CPR; (2) CPR interposed with abdominal compression (IAC-CPR); and (3) SCAC-CPR. Standard CPR was repeated at the end of each sequence. Thoracic aortic and right atrial pressures were recorded during maneuvers and no vasoactive drugs were administered. Systolic aortic pressures were 39.02 +/- 21 mmHg, 63.6 +/- 21 mmHg and 94.04 +/- 21 mmHg during standard CPR, IAC-CPR and SCAC-CPR, respectively (P less than 0.001). There was no evidence of intra-abdominal injury in the eight autopsies performed. We have reached the conclusion that the use of SCAC-CPR on humans does produce greater intravascular pressure and we recommend this technique as a possible alternative to standard CPR.

Aged↗